Ads
related to: prometheus labs ipoThe IPO Market is Hotter Than Ever. This is a Phenomenal Time for Savvy Investors. The 2024 IPO lineup includes a company that could be one the biggest of all time.
- Chipmaker Set to Soar Now
Best 2024 Semiconductor Stock?
One Chipmaker Worth Buying Now
- Top EV Stocks to Buy Now
5 EV Picks Better than Tesla
5 Stocks with Big Profit Potential
- Zacks Memberships
Sign Up Free For Daily Alerts
Profit From The Pros With Zacks
- Free Portfolio Tracker
Get Daily Online & Email Alerts
For All Stocks, ETFs, & Mutal Funds
- Chipmaker Set to Soar Now
Invest in trending private tech companies & unicorns before they IPO. Get access for free. A leading provider of technology, exclusive data, and services for the private market.
Search results
$19.00 per share
- SAN DIEGO, March 16, 2021 /PRNewswire/ -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease (IBD), today announced the closing of its initial public offering of 11,500,000 shares of common stock, which includes the exercise in full by the underwriters of their option to purchase...
www.prnewswire.com › news-releases › prometheus-biosciences-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares-301248704Prometheus Biosciences Announces Closing of Initial Public ...
People also ask
Will Merck MRK buy Prometheus Biosciences (RXDX)?
When do Prometheus shares start trading?
Why did Merck buy Prometheus?
How much money will Prometheus offer?
Mar 16, 2021 · SAN DIEGO, March 16, 2021 /PRNewswire/ -- Prometheus Biosciences, Inc. (Nasdaq: RXDX ), a biotechnology company pioneering a precision medicine approach for the discovery, development, and...
Jun 16, 2023 · Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn’s disease and other autoimmune conditions. June 16, 2023 ...
Mar 12, 2021 · Prometheus Laboratories provided laboratory developed tests that gastroenterologists use in monitoring disease in IBD patients, helping to inform treatment decisions, according to the IPO...
Apr 17, 2023 · Pharma goliath, Merck MRK and Prometheus Biosciences, Inc RXDX, together announced entering a definitive agreement where the former is set to acquire the latter, through a subsidiary for $200 per...
Mar 12, 2021 · SAN DIEGO, March 11, 2021 /PRNewswire/ -- Prometheus Biosciences, Inc. (Nasdaq: RXDX ), a biotechnology company pioneering a precision medicine approach for the discovery, development, and...
Mar 11, 2021 · Published: March 11, 2021 at 6:36 a.m. ET. By. Tomi Kilgore. Referenced Symbols. IPO. +0.25% SPX. +0.13% Prometheus Biosciences Inc. rxdx disclosed Thursday that it increased the number of...
Apr 17, 2023 · Merck & Co. has agreed to acquire Prometheus Biosciences for about $10.8 billion, the companies said Sunday, in a deal intended to bolster the buyer’s immunology drug pipeline as it faces loss of exclusivity for some of its best-selling products over the next few years.
Ads
related to: prometheus labs ipoThe IPO Market is Hotter Than Ever. This is a Phenomenal Time for Savvy Investors. The 2024 IPO lineup includes a company that could be one the biggest of all time.
Interactive Brokers clients from 200+ countries and territories invest globally. Invest globally in stocks, options, futures, currencies, bonds & funds from one screen.
schwab.com has been visited by 100K+ users in the past month
Get $101 Of Schwab Stock Slices To Split Across The Top Five Stocks In The S&P 500®. Get The Tools You Need To Help You Make Smarter Trading Decisions. Learn More.
